Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medtronic (NY: MDT )

90.07 +0.82 (+0.92%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
46 47 Next >
1 Green Flag and 1 Red Flag For Medtronic
Medtronic shares are on the rise. 
Via The Motley Fool
3 Biotech Stocks Using AI to Change Healthcare Forever
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
Aligning Strategies with Market Realities: Medtronic Addresses Performance Pressure for Investor Benefit during Decreased ProfitsMedtronic: Weathering Market Challenges with Steady Dividends
Via Benzinga
Axonics Positioned For Rapid Penetration In Underserved Market, Analyst Initiates With Bullish Tone
KeyBanc Capital markets initiated coverage on Axonics Inc (NASDAQ: AXNX) with an Overweight rating and a  
Via Benzinga
Tesla's New $1,670 Electric Quad Bike for Kids, Meta Seeks To Release Commercial AI Model, YouTube Stars' Energy Drink Under FDA Review: Today's Top Stories
Financial Times Meta Platforms Seeks To Launch Commercial Version Of Its Artificial Intelligence Model 
Via Benzinga
Peering Into Medtronic's Recent Short Interest
Via Benzinga
Better Buy: Medtronic vs. Intuitive Surgical
Both medical device companies are doing well, but one has a tremendous future. 
Via The Motley Fool
What 11 Analyst Ratings Have To Say About Medtronic
Via Benzinga
2 Top Healthcare Stocks to Buy Right Now
The need for healthcare goods and services isn't going anywhere anytime soon. 
Via The Motley Fool
Whistleblower Lawsuit Alleges Bribery Scheme: Medtronic Denies Allegations of Kickback Scheme, Endangering Patients' Lives
Sales representatives from Medtronic plc (NYSE: MDT) allegedly operated a bribery scheme at a Kansas veterans hospital. 
Via Benzinga
Emergency Medical Service Market Boosting the Growth Worldwide
Stay up-to-date with Emergency Medical Service Market research offered by AMA. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
These 3 Health Care Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
3 Top Healthcare Stocks to Buy for July
Three medical device stocks that make solid long-term investments. 
Via The Motley Fool
Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy
Inspire Medical Systems has surged nearly 15% since its breakout, driven by positive Q1 results and FDA approvals. Analysts have a "buy" rating on the stock. 
Via MarketBeat
Exposures Product Safety
3 Elite Dividend Stocks Yielding 3%-Plus to Buy Without Hesitation in July
These companies offer attractive and steadily rising income streams. 
Via The Motley Fool
Ventilators Market is expected to grow at a CAGR of 11.65% for the forecast period of 2023-2028, Estimates DelveInsight | Hamilton Medical, Medtronic, Vyaire Medical, Getinge AB, ResMed, Air Liquide
Via AB Newswire
3 Dividend Growth Stocks to Buy in July and Never Sell
Holding these stocks over the long run could lead to heaps of dividend income in your retirement years. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
Via Benzinga
The 3 Most Undervalued Retirement Stocks to Buy Now: June 2023
Discover undervalued retirement stocks and dividend stocks for your retirement portfolio. Maximize your returns with these quality picks. 
Via InvestorPlace
Better Artificial Intelligence Stock: Medtronic or Arista Networks?
These early AI adopters are both attractive investing vehicles. But one stock is the better buy. 
Via The Motley Fool
3 Dividend Stocks With Massive Payout Ratios
Dividend stock yield is only half the equation for income investment strategies, and these high payout ratios indicate sustainable dividends. 
Via InvestorPlace
The Best Stocks to Invest $20,000 in Right Now
You can invest in these companies with $20,000 -- or even a lot less. 
Via The Motley Fool
Medtronic Says New Data For MiniMed 780G Supports Use In Children With Diabetes
Medtronic plc (NYSE: MDT) presented new clinical and real-world data on the MiniMed 780G system at the 83rd American Diabetes  
Via Benzinga
Aortic Stenosis Market to witness growth by 2032, estimates DelveInsight | Boston Scientific Corporation, Medtronic plc, Novartis, Boston Scientific Corporation, Abbott, LivaNova, Edward Lifescience
Via AB Newswire
Lenegre’s Disease Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies| Companies – Biotronic Inc, Abbott Pharmaceuticals, Medtronic Inc
Via AB Newswire
Dexcom, A Top 2% Stock, Raises 2025 Outlook Amid 'Rapidly' Expanding Diabetes Market
The company makes continuous glucose monitors for patients with diabetes. 
Via Investor's Business Daily
Elective Surgeries Are On the Rise: 3 Stocks That Can Benefit From This Trend
These have been some of the hottest healthcare stocks on the markets this year. 
Via The Motley Fool
AI May Transform Healthcare: 2 Top Stocks to Buy Now
These players already are using AI -- and could become AI leaders over time. 
Via The Motley Fool
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval
The FDA has approved Surmodics Inc's (NASDAQ: SRDX) SurVeil drug-coated balloon (DCB), a next-generation device  
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 19
...
46 47 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.